| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.37 | 0.06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.06 |